CRASH-2: Prosecution’s Closing Statement
The comments regarding our recent post about the limitations of the CRASH-2 trial focus on definitions of trial design and purpose, the relative importance of those limitations in reducing the […]
Dr. Mark Walsh
The Use of TEG & Goal Directed Blood Component Therapy
One of the leading experts in the use of thromboelastography (TEG) is Dr. Mark Walsh from South Bend, Indiana. We were fortunate enough to have Dr. Walsh come all the
